PepGen (PEPG) Change in Accured Expenses (2021 - 2026)
PepGen (PEPG) reported Change in Accured Expenses of -$3.5 million for Q1 2026, down 230.06% on a YoY basis from $2.7 million in Q1 2025, and down 1482.75% sequentially from $255000.0 in Q4 2025.
PepGen (PEPG) Change in Accured Expenses (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Change in Accured Expenses data on file, last reported at -$3.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses fell 230.06% year-over-year to -$3.5 million; the trailing twelve-month figure through Mar 2026 stood at -$9.5 million (down 221.66% YoY), and the FY2025 full-year result was -$3.3 million, down 96.51% from the prior year.
- Change in Accured Expenses slipped to -$3.5 million in Q1 2026, from $255000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $6.5 million in Q1 2022 to a low of -$6.8 million in Q1 2024.
- A 5-year average of -$88470.6 and a median of $166000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 829.66% in 2024, while the deepest fall reached 4175.3% in 2024.
- Tracing PEPG's Change in Accured Expenses over 5 years: stood at $2.1 million in 2022, then tumbled by 127.42% to -$563000.0 in 2023, then soared by 825.93% to $4.1 million in 2024, then plunged by 93.76% to $255000.0 in 2025, then slumped by 1482.75% to -$3.5 million in 2026.
- Business Quant data shows PEPG's Change in Accured Expenses at -$3.5 million in Q1 2026, $255000.0 in Q4 2025, and -$4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | -3.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.53 Mn |
| Mar 31, 2026 | -3.53 Mn |
| Dec 31, 2025 | 255,000.00 |
| Dec 31, 2025 | 255,000.00 |
| Sep 30, 2025 | -4.02 Mn |
| Sep 30, 2025 | -4.02 Mn |
| Jun 30, 2025 | -2.22 Mn |
| Jun 30, 2025 | -2.22 Mn |
| Mar 31, 2025 | 2.71 Mn |
| Mar 31, 2025 | 2.71 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Sep 30, 2024 | -3.49 Mn |
| Sep 30, 2024 | -3.49 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Mar 31, 2024 | -6.77 Mn |
| Mar 31, 2024 | -6.77 Mn |
| Dec 31, 2023 | -563,000.00 |
| Dec 31, 2023 | -563,000.00 |